PT85880B - Processo para a preparacao de composicoes farmaceuticas de accao retardada contendo como substancia veicular uma mistura de celulose microcristalina com hidroxipropil-metilcelulose - Google Patents

Processo para a preparacao de composicoes farmaceuticas de accao retardada contendo como substancia veicular uma mistura de celulose microcristalina com hidroxipropil-metilcelulose Download PDF

Info

Publication number
PT85880B
PT85880B PT85880A PT8588087A PT85880B PT 85880 B PT85880 B PT 85880B PT 85880 A PT85880 A PT 85880A PT 8588087 A PT8588087 A PT 8588087A PT 85880 B PT85880 B PT 85880B
Authority
PT
Portugal
Prior art keywords
preparation
composition according
approximately
microcrystalline cellulose
hydroxypropyl methylcellulose
Prior art date
Application number
PT85880A
Other languages
English (en)
Portuguese (pt)
Other versions
PT85880A (en
Inventor
Henry C Gan
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of PT85880A publication Critical patent/PT85880A/pt
Publication of PT85880B publication Critical patent/PT85880B/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PT85880A 1986-10-09 1987-10-07 Processo para a preparacao de composicoes farmaceuticas de accao retardada contendo como substancia veicular uma mistura de celulose microcristalina com hidroxipropil-metilcelulose PT85880B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868624213A GB8624213D0 (en) 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions

Publications (2)

Publication Number Publication Date
PT85880A PT85880A (en) 1987-11-01
PT85880B true PT85880B (pt) 1990-07-31

Family

ID=10605478

Family Applications (1)

Application Number Title Priority Date Filing Date
PT85880A PT85880B (pt) 1986-10-09 1987-10-07 Processo para a preparacao de composicoes farmaceuticas de accao retardada contendo como substancia veicular uma mistura de celulose microcristalina com hidroxipropil-metilcelulose

Country Status (24)

Country Link
JP (1) JPS63101334A (de)
KR (1) KR880004801A (de)
AU (1) AU7942087A (de)
BE (1) BE1000732A5 (de)
CA (1) CA1332809C (de)
CH (1) CH675831A5 (de)
DE (1) DE3733540A1 (de)
DK (1) DK527487A (de)
ES (1) ES2014518A6 (de)
FI (1) FI874414A (de)
FR (1) FR2604902B1 (de)
GB (2) GB8624213D0 (de)
GR (1) GR871550B (de)
HU (1) HU201875B (de)
IL (1) IL84104A0 (de)
IT (1) IT1221493B (de)
LU (1) LU87009A1 (de)
NL (1) NL8702294A (de)
NO (1) NO874200L (de)
NZ (1) NZ222083A (de)
PH (1) PH24227A (de)
PT (1) PT85880B (de)
SE (1) SE8703889L (de)
ZA (1) ZA877617B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
EA005291B1 (ru) 1999-03-31 2004-12-30 Янссен Фармацевтика Н.В. Применение предварительно желатинированного крахмала в композиции с контролируемым высвобождением
US6242003B1 (en) 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US20060127474A1 (en) 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
SE0102888D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102887D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102886D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
CN101039661A (zh) * 2004-09-09 2007-09-19 普西考法玛公司 用于肼苯哒嗪缓释的药物组合物及其作为癌症治疗载体的用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795766A (fr) * 1972-02-22 1973-08-22 Lilly Co Eli Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
DE3346571A1 (de) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen Oral retardierte acetylsalicylsaeureformulierungen
AU4064285A (en) * 1984-03-21 1985-10-11 American Home Products Corporation Sustained release pharmaceutical capsules

Also Published As

Publication number Publication date
SE8703889L (sv) 1988-04-10
IT1221493B (it) 1990-07-06
GB8624213D0 (en) 1986-11-12
GB2195893B (en) 1991-05-08
DK527487A (da) 1988-04-10
CH675831A5 (de) 1990-11-15
CA1332809C (en) 1994-11-01
HUT52958A (en) 1990-09-28
SE8703889D0 (sv) 1987-10-08
GR871550B (en) 1988-02-15
PT85880A (en) 1987-11-01
BE1000732A5 (fr) 1989-03-21
ES2014518A6 (es) 1990-07-16
DE3733540A1 (de) 1988-04-14
DK527487D0 (da) 1987-10-08
KR880004801A (ko) 1988-06-27
JPS63101334A (ja) 1988-05-06
NO874200D0 (no) 1987-10-07
NO874200L (no) 1988-04-11
NL8702294A (nl) 1988-05-02
FI874414A (fi) 1988-04-10
ZA877617B (en) 1989-05-30
HU201875B (en) 1991-01-28
IT8748469A0 (it) 1987-10-08
GB2195893A (en) 1988-04-20
GB8723515D0 (en) 1987-11-11
NZ222083A (en) 1991-05-28
FR2604902B1 (fr) 1991-04-26
FI874414A0 (fi) 1987-10-07
FR2604902A1 (fr) 1988-04-15
LU87009A1 (fr) 1988-05-03
IL84104A0 (en) 1988-03-31
AU7942087A (en) 1988-04-14
PH24227A (en) 1990-05-04

Similar Documents

Publication Publication Date Title
Bredenberg et al. In vitro and in vivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance
JP4976011B2 (ja) 制御放出モルヒネ製剤
ES2301537T3 (es) Comprimidos y formulacion de guaifenesina de liberacion sostenida.
CA2406373C (en) Controlled release paracetamol composition
US20010012518A1 (en) Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
SE453797B (sv) Terapeutisk, solid enhetsdoseringsform med forlengt utlosningsmonster vars berarmaterial innehaller hydroxypropylmetylcellulosa med hog molekyler vikt
PT86212B (pt) Processo para a preparacao de uma formulacao galenica
JPH02104A (ja) 薬物放出速度調節型製剤
BR112014006356B1 (pt) Comprimido sublingual, processo para a preparação do mesmo e seu uso
CZ292513B6 (cs) Přípravek poskytující regulované uvolňování léků rozpustných ve vodě
BRPI0511520B1 (pt) material particulado, forma de dosagem sólida, e, processos para a preparação de um material particulado, e para preparar um comprimido
AU2001260212A1 (en) Composition
PT85128B (pt) Processo para a preparacao de composicoes farmaceuticas contendo, como ingrediente activo, 4-(1-metil-4-piperidilideno)-4h-benzo-{4,5}ciclohepta{1,2-b}tiofeno--10(9h)-ona
JPH07112973B2 (ja) イブプロフェン又はその塩を活物質とする可溶性の消炎性組成物及びその製造方法
BRPI0513938B1 (pt) composição farmacêutica contendo drospirenona e etinilestradiol
WO2023241688A1 (zh) 一种用于治疗抗凝血的药物组合物及应用
PT85880B (pt) Processo para a preparacao de composicoes farmaceuticas de accao retardada contendo como substancia veicular uma mistura de celulose microcristalina com hidroxipropil-metilcelulose
JP2004533461A (ja) パラセタモールを含む嚥下錠剤
GB2154874A (en) Bromocriptine compositions
WO2005029980A1 (ja) システイン類の不快な臭気又は味が軽減された組成物
KR20050009983A (ko) 트라마돌의 서방성 제제
TWI286072B (en) Sleeping medicine formed by coating solid
EP1469848A1 (de) Sedierende nicht-benzodiazepin-formulierungen
KR101046789B1 (ko) 안정성이 개선된 암로디핀 속붕해성 정제 및 그의 제조방법
WO2004062564A2 (en) Sedative non-benzodiazepine formulations

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19940731